TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17,686 Cr | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹17,686 Cr |
| Mar2025 | ₹2,088 Cr |
| Mar2024 | ₹2,224 Cr |
| Mar2023 | ₹2,823 Cr |
| Mar2022 | ₹2,238 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,686 Cr | 747.13 | |
| Mar2025 | ₹2,088 Cr | -6.13 | |
| Mar2024 | ₹2,224 Cr | -21.21 | |
| Mar2023 | ₹2,823 Cr | 26.12 | |
| Mar2022 | ₹2,238 Cr | - | |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹185,494.5 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
| MANKIND PHARMA | ₹99,862.4 Cr | -0.9% | -5.1% | -5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.5% |
-2.8% |
38.7% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses